We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock
AXLA

Delisted

AXLA was delisted on the 22nd of November, 2023.

Back to rankings

38 hedge funds and large institutions have $87M invested in Axcella Health Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

35,500% more call options, than puts

Call options by funds: $356K | Put options by funds: $1K

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

73% more capital invested

Capital invested by funds: $50.4M → $87M (+$36.6M)

9% more funds holding

Funds holding: 35 → 38 (+3)

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

Holders
38
Holders Change
+3
Holders Change %
+8.57%
% of All Funds
0.6%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
11
Reduced
12
Closed
3
Calls
$356K
Puts
$1K
Net Calls
+$355K
Net Calls Change
+$61K

Top Buyers

Rank Fund Capital Flow
1
FP
Flagship Pioneering
Massachusetts
+$12.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.92M
3
HP
Harbourvest Partners
Massachusetts
+$3.14M
4
BCM
Bridgeway Capital Management
Texas
+$160K
5
Edgewood Management
Edgewood Management
Connecticut
+$49.9K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$305K
2
VF
Virtu Financial
New York
-$47K
3
Citadel Advisors
Citadel Advisors
Florida
-$32.6K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$21K
5
LC
Lindbrook Capital
California
-$17K
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
26
Simplex Trading
Illinois
$8K +$6.99K +140 New
TRCT
27
Tower Research Capital (TRC)
New York
$5K -$3.44K -69 -48%
First Manhattan
28
First Manhattan
New York
$5K – – –
Morgan Stanley
29
Morgan Stanley
New York
$4K -$150 -3 -4%
Wells Fargo
30
Wells Fargo
California
$3K -$599 -12 -21%
APA
31
American Portfolios Advisors
New York
$1.03K – – –
JP Morgan Chase
32
JP Morgan Chase
New York
$1K – – –
Northwestern Mutual Wealth Management
33
Northwestern Mutual Wealth Management
Wisconsin
$1K +$599 +12 New
Federated Hermes
34
Federated Hermes
Pennsylvania
$1K +$998 +20 New
MCC
35
Money Concepts Capital
Florida
$1K +$1.05K +21 New
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$46 -$499 -10 -91%
VF
37
Virtu Financial
New York
– -$47K -898 Closed
Citadel Advisors
38
Citadel Advisors
Florida
– -$32.6K -654 Closed
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
– -$21K -401 Closed
Bank of America
40
Bank of America
North Carolina
– -$499 -10 -83%
GRP
41
Global Retirement Partners
California
– +$349 +7 New
1
2

AXLA Hedge Fund Activity: Q1 2022 in Review

38 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q1 2022, worth a combined $87M — up 73% from $50.4M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new AXLA positions and 3 closed out — a net gain of 3 holders — while 11 added to existing stakes and 12 trimmed.

The largest buyer was Flagship Pioneering, adding an estimated $12.6M. The largest seller was Vanguard Group, cutting an estimated $305K.

  • 38 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q1 2022, up from 35 in Q4 2021.
  • Funds reported $87M of Axcella Health Inc. Common Stock stock for Q1 2022, up 73% quarter-over-quarter.
  • 6 funds opened new Axcella Health Inc. Common Stock positions in Q1 2022 and 3 closed out, a net change of +3 holders.
  • The largest Axcella Health Inc. Common Stock buyer in Q1 2022 was Flagship Pioneering, an estimated $12.6M added.
  • The largest Axcella Health Inc. Common Stock seller in Q1 2022 was Vanguard Group, an estimated $305K sold.

Based on aggregated 13F filings for Q1 2022.